Phase II trial of ICRF-187 in children with solid tumors and acute leukemia

Publisher Website

1 November 1991

journal article
clinical trial
Published by Springer Nature in Investigational New Drugs

Vol. 9 (4), 333-337
https://doi.org/10.1007/bf00183575

Abstract

No abstract available

Keywords

This publication has 5 references indexed in Scilit:

Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast Cancer
New England Journal of Medicine, 1988
PHASE-I STUDY OF ICRF-187 IN PEDIATRIC CANCER-PATIENTS AND COMPARISON OF ITS PHARMACOKINETICS IN CHILDREN AND ADULTS
1986
Phase I study of ICRF-187 using a daily for 3 days schedule.
1981
Utilization of an enantiomer as a solution to a pharmaceutical problem: Application to solubilization of 1,2‐di(4‐piperazine‐2,6‐dione)propane
Journal of Pharmaceutical Sciences, 1976
The bioavailability in man of ICRF-159 a new oral antineoplastic agent
Journal of Pharmacy and Pharmacology, 1975

Cited by 13 articles